Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001753926-25-001803
Filing Date
2025-11-14
Accepted
2025-11-14 16:42:42
Documents
6
Period of Report
2025-11-14

Document Format Files

Seq Description Document Type Size
1 g085012_pre14a.htm PRE 14A 583320
2 GRAPHIC img001_v1.jpg GRAPHIC 36006
3 GRAPHIC img002_v1.jpg GRAPHIC 36006
4 GRAPHIC img003_v1.jpg GRAPHIC 1542276
5 GRAPHIC img004_v1.jpg GRAPHIC 213980
6 GRAPHIC img005_v1.jpg GRAPHIC 51330
  Complete submission text file 0001753926-25-001803.txt   3170801
Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41964 | Film No.: 251487529
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)